Trial intelligence / Profile preview

Dexamethasone vs Dexmedetomidine as Adjuvant to Bupivacaine in Spinal Anesthesia for Pelvic Fracture Fixation

NCT07485127Phase 1Active, not recruiting

Sponsor
Sohag University
Start
Feb 2026
Primary completion
Aug 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised trial in pelvic fracture comparing Dexamethasone Group with Dexmedetomidine Group (2 arms). Primary endpoint: Duration of sensory block. Started Feb 2026; status: active, not recruiting.

02

Drugs

dexamethasonedexmedetomidine
03

Conditions

pelvic fracture

Beyond the preview

Go deeper on NCT07485127.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07485127.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call